Analysts’ Updated EPS Estimates for August 14th (ADIG, ALMS, AMAT, ANTO, ARX, ATEN, AVR, BIRK, BRUN, BZAI)

Analysts’ updated eps estimates for Friday, August 14th:

Seaport Research Partners began coverage on shares of ADI Global Distribution Inc. Common Stock (NYSE:ADIG). They issued a buy rating and a $35.00 target price on the stock.

Alumis (NASDAQ:ALMS) had its neutral rating reiterated by analysts at HC Wainwright. They currently have a $25.00 target price on the stock.

Applied Materials (NASDAQ:AMAT) had its buy rating reiterated by analysts at TD Cowen. TD Cowen currently has a $700.00 price target on the stock.

Applied Materials (NASDAQ:AMAT) had its buy rating reissued by analysts at B. Riley Financial, Inc.. B. Riley Financial, Inc. currently has a $700.00 price target on the stock, down from their previous price target of $790.00.

Applied Materials (NASDAQ:AMAT) had its buy rating reissued by analysts at Needham & Company LLC. They currently have a $740.00 price target on the stock.

Antofagasta (LON:ANTO) had its hold rating reiterated by analysts at Berenberg Bank. Berenberg Bank currently has a GBX 4,400 price target on the stock.

Antofagasta (LON:ANTO) had its sell rating reiterated by analysts at Deutsche Bank Aktiengesellschaft. The firm currently has a GBX 3,400 price target on the stock.

Accelerant (NYSE:ARX) had its market perform rating reissued by analysts at Citizens Jmp.

A10 Networks (NYSE:ATEN) had its buy rating reissued by analysts at BWS Financial. The firm currently has a $45.00 price target on the stock.

Anteris Technologies Global (NASDAQ:AVR) had its overweight rating reissued by analysts at Cantor Fitzgerald. They currently have a $15.00 price target on the stock.

Birkenstock (NYSE:BIRK) had its buy rating reissued by analysts at Guggenheim. They currently have a $60.00 price target on the stock.

Birkenstock (NYSE:BIRK) had its buy rating reiterated by analysts at BTIG Research. The firm currently has a $60.00 target price on the stock.

Boost Run (NASDAQ:BRUN) had its buy rating reaffirmed by analysts at BTIG Research. They currently have a $45.00 price target on the stock.

Blaize (NASDAQ:BZAI) had its neutral rating reaffirmed by analysts at DA Davidson. The firm currently has a $1.00 price target on the stock, down from their previous price target of $3.00.

Celcuity (NASDAQ:CELC) had its buy rating reissued by analysts at HC Wainwright. The firm currently has a $155.00 target price on the stock.

Cinemark (NYSE:CNK) was downgraded by analysts at JPMorgan Chase & Co. from an overweight rating to a neutral rating. They currently have $39.00 target price on the stock, down from their previous target price of $40.00.

Cisco Systems (NASDAQ:CSCO) had its hold rating reiterated by analysts at HSBC Holdings plc. The firm currently has a $120.00 target price on the stock, down from their previous target price of $137.00.

Cranswick (LON:CWK) had its house stock rating reissued by analysts at Shore Capital Group Ltd.

Brinker International (NYSE:EAT) was downgraded by analysts at Northcoast Research from a buy rating to a neutral rating.

Fate Therapeutics (NASDAQ:FATE) had its outperform rating reaffirmed by analysts at Wedbush. Wedbush currently has a $7.00 target price on the stock.

Figure Technology Solutions (NASDAQ:FIGR) had its buy rating reiterated by analysts at Needham & Company LLC. The firm currently has a $55.00 price target on the stock.

FOX (NASDAQ:FOX) was upgraded by analysts at JPMorgan Chase & Co. from a neutral rating to an overweight rating. JPMorgan Chase & Co. currently has $82.00 target price on the stock, up from their previous target price of $70.00.

FOX (NASDAQ:FOXA) was upgraded by analysts at JPMorgan Chase & Co. from a neutral rating to an overweight rating. They currently have $82.00 target price on the stock, up from their previous target price of $70.00.

Leerink Partners assumed coverage on shares of Freenome (NASDAQ:FRNM). Leerink Partners issued an outperform rating and a $18.00 price target on the stock.

ForViva (LON:FVA) had its buy rating reissued by analysts at Canaccord Genuity Group Inc.. They currently have a GBX 190 target price on the stock.

Hilton Food Group (LON:HFG) had its house stock rating reiterated by analysts at Shore Capital Group Ltd.

IG Group (LON:IGG) had its outperform rating reissued by analysts at Royal Bank Of Canada. Royal Bank Of Canada currently has a GBX 1,850 target price on the stock.

KinderCare Learning Companies (NYSE:KLC) was downgraded by analysts at JPMorgan Chase & Co. from a neutral rating to an underweight rating.

LGN (NASDAQ:LGN) had its buy rating reaffirmed by analysts at BTIG Research. The firm currently has a $100.00 price target on the stock, down from their previous price target of $120.00.

Leerink Partners initiated coverage on shares of Ligand Pharmaceuticals (NASDAQ:LGND). Leerink Partners issued an outperform rating on the stock.

Microbot Medical (NASDAQ:MBOT) had its buy rating reiterated by analysts at B. Riley Financial, Inc.. The firm currently has a $4.00 target price on the stock, down from their previous target price of $5.00.

Maestrano Group (LON:MNO) had its buy rating reissued by analysts at Berenberg Bank. Berenberg Bank currently has a GBX 168 target price on the stock.

Micron Technology (NASDAQ:MU) was upgraded by analysts at New Street Research from a neutral rating to a buy rating. The firm currently has $1,250.00 price target on the stock.

Murphy Oil (NYSE:MUR) was downgraded by analysts at Barclays PLC from an equal weight rating to an underweight rating. The firm currently has $34.00 target price on the stock, down from their previous target price of $38.00.

Nomad Foods (NYSE:NOMD) had its buy rating reiterated by analysts at BTIG Research. They currently have a $15.00 target price on the stock.

Nayax (NASDAQ:NYAX) was upgraded by analysts at Keefe, Bruyette & Woods from a market perform rating to an outperform rating. Keefe, Bruyette & Woods currently has $75.00 price target on the stock.

Ondas (NASDAQ:ONDS) had its buy rating reissued by analysts at Needham & Company LLC. They currently have a $19.00 target price on the stock.

Oncobiologics (NASDAQ:OTLK) had its buy rating reissued by analysts at BTIG Research. BTIG Research currently has a $4.00 price target on the stock.

PensionBee Group (LON:PBEE) had its buy rating reaffirmed by analysts at Canaccord Genuity Group Inc.. Canaccord Genuity Group Inc. currently has a GBX 217 price target on the stock.

Plexus (NASDAQ:PLXS) had its buy rating reiterated by analysts at Needham & Company LLC. Needham & Company LLC currently has a $310.00 price target on the stock.

Canaccord Genuity Group Inc. started coverage on shares of Proservice Building Services Marketplace (LON:PRO). The firm issued a speculative buy rating and a GBX 5 target price on the stock.

Avidity Biosciences (NASDAQ:RNA) had its buy rating reissued by analysts at HC Wainwright. The firm currently has a $25.00 target price on the stock.

Semtech (NASDAQ:SMTC) had its buy rating reiterated by analysts at Needham & Company LLC. They currently have a $200.00 price target on the stock.

JPMorgan Chase & Co. initiated coverage on shares of Sandisk (NASDAQ:SNDK). The firm issued an overweight rating and a $2,250.00 target price on the stock.

Sandisk (NASDAQ:SNDK) had its outperform rating reissued by analysts at Wedbush. The firm currently has a $2,000.00 price target on the stock.

SoundThinking (NASDAQ:SSTI) was downgraded by analysts at Lake Street Capital from a buy rating to a hold rating. Lake Street Capital currently has $8.00 price target on the stock.

SoundThinking (NASDAQ:SSTI) had its market perform rating reiterated by analysts at Citizens Jmp.

Savills (LON:SVS) had its buy rating reiterated by analysts at Berenberg Bank. The firm currently has a GBX 1,375 price target on the stock.

Savills (LON:SVS) had its buy rating reiterated by analysts at Deutsche Bank Aktiengesellschaft. The firm currently has a GBX 1,343 target price on the stock.

T-Mobile US (NASDAQ:TMUS) had its peer perform rating reissued by analysts at Wolfe Research.

Workday (NASDAQ:WDAY) had its neutral rating reiterated by analysts at Piper Sandler. They currently have a $145.00 target price on the stock.

X-Energy (NASDAQ:XE) had its overweight rating reissued by analysts at Cantor Fitzgerald. They currently have a $38.00 price target on the stock.

Zenas BioPharma (NASDAQ:ZBIO) had its buy rating reiterated by analysts at Guggenheim. The firm currently has a $55.00 price target on the stock.

Zenas BioPharma (NASDAQ:ZBIO) had its outperform rating reissued by analysts at Wedbush. They currently have a $45.00 price target on the stock.